Form S-1/A Sonnet BioTherapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Sonnet BioTherapeutics (SONN) Files for 1.1M Share and Warrant Offering
November 6, 2024 9:25 AM ESTSonnet BioTherapeutics (NASDAQ: SONN) has filed the following:
We are offering 1,103,752 shares of our common stock and common warrants to purchase an aggregate of 2,207,504 shares of our common stock, par value $0.0001 per share (and the shares of common stock that are issuable from time to time upon exercise of the common warrants), at an assumed combined public offering price of $4.53, which is the last reported sale price of our common stock on October 31, 2024. We are also offering to certain purchasers whose purchase of shares of common stock in this offering would otherwise... More
